Nath Bio-Genes (India) Ltd (NATHBIOGEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 628630, "name": "Nath Bio-Genes", "stock_name": "Nath Bio-Genes", "full_name": "Nath Bio-Genes (India) Ltd", "name_url": "stocks-analysis/nath-bio-genes", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "165.00", "chg": 0.05, "chgp": "0.03%", "dir": 1, "prev_price": "164.95", "mcapval": "314.00 Cr", "mcap": "Micro Cap", "scripcode": 537291, "symbol": "NATHBIOGEN", "ind_name": "Other Agricultural Products", "ind_code": 107, "sector_id": 53, "indexname": "India SENSEX", "isin": "INE448G01010", "curr_date": "Jun 12, 10:43 AM", "curr_time": "10:45 AM", "last_traded_at": "Jun 12, 10:43 AM IST", "bse_nse_vol": "8.18 k", "exc_status": "Active", "traded_date": "Jun 12, 2026", "traded_date_str": "2026 06 12", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nath-bio-genes-628630-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Nath Bio-Genes Downgraded to Sell Amid Flat Financials and Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-sell-amid-flat-financials-and-weak-fundamentals-4040521", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_mojoScore_4040521.png", "date": "2026-06-09 08:52:03", "description": "Nath Bio-Genes (India) Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 8 June 2026, reflecting concerns over its stagnant financial performance, weak long-term fundamentals, and consistent underperformance against market benchmarks. Despite a very attractive valuation, the company’s deteriorating financial trends and technical indicators have prompted a cautious stance from analysts." }, { "title": "Nath Bio-Genes (India) Ltd Upgraded to Hold on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-4030270", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_mojoScore_4030270.png", "date": "2026-06-02 09:05:41", "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating upgraded from Sell to Hold as of 1 June 2026. This change reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite persistent challenges in long-term fundamentals, recent technical signals and valuation metrics have improved sufficiently to warrant a more cautious but optimistic stance." }, { "title": "Golden Cross Confirmed: Do Nath Bio-Genes' Other Technical Indicators Agree?", "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-forms-golden-cross-signalling-potential-bullish-breakout-4027111", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_goldencross_4027111.png", "date": "2026-06-01 18:00:30", "description": "The 50-day moving average for Nath Bio-Genes (India) Ltd has crossed above the 200-day moving average, signalling a golden cross on 1 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a more nuanced picture that merits careful analysis." }, { "title": "Nath Bio-Genes (India) Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4004876", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_mojoScore_4004876.png", "date": "2026-05-22 10:10:40", "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company's performance and outlook." }, { "title": "Nath Bio-Genes (India) Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-3985456", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_mojoScore_3985456.png", "date": "2026-05-11 10:10:28", "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Nath Bio-Genes Falls 9.61% Amid Profit Wipeout and Mixed Financial Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-falls-961-amid-profit-wipeout-and-mixed-financial-signals-3983506", "imagepath": "", "date": "2026-05-09 16:08:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 5:</strong> Profit wipeout amid tax anomaly raises red flags</p>\n <p><strong>May 6:</strong> Flat quarterly performance reported with mixed financial trends</p>\n <p><strong>May 8:</strong> Week closes at Rs.171.15, down 9.61%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.189.35</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.171.15</div><div class=\"stat-change negative\">-9.61%</div></div>\n <div class=\"stat-item\"><div cl..." }, { "title": "Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends", "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-reports-flat-quarterly-performance-amid-mixed-financial-trends-3977731", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_fintrenddot_3977731.png", "date": "2026-05-06 11:00:16", "description": "Nath Bio-Genes (India) Ltd has reported a flat financial performance for the quarter ended March 2026, signalling a stabilisation after a period of decline. While net sales have shown robust growth, profitability metrics and earnings per share continue to face headwinds, reflecting a complex financial landscape for this micro-cap player in the Other Agricultural Products sector." }, { "title": "Are Nath Bio-Genes (India) Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-nath-bio-genes-india-ltd-latest-results-good-or-bad-3976442", "imagepath": "", "date": "2026-05-05 19:16:48", "description": "Nath Bio-Genes (India) Ltd reported its financial results for Q4 FY26, revealing a complex operational landscape. The company experienced a net profit of -₹0.01 crores, reflecting a significant decline of 100.68% year-on-year. This loss was primarily driven by an unusually high effective tax rate of 100.40%, which exceeded the pre-tax profit of ₹2.49 crores, effectively nullifying earnings for the quarter. \n\nIn terms of revenue, Nath Bio-Genes recorded net sales of ₹51.59 crores, which represents a slight decline of 0.73% compared to the same quarter last year. However, this figure marked a more pronounced quarter-on-quarter decrease of 21.79% from ₹65.96 crores in Q3 FY26, indicating volatility in sales performance. The operating margin improved to 8.68%, a notable increase from 0.79% in Q4 FY25, suggesting some operational efficiency gains despite the overall profit loss.\n\nThe company’s financial performa..." }, { "title": "Nath Bio-Genes Q4 FY26: Profit Wipeout Amid Tax Anomaly Raises Red Flags", "link": "https://www.marketsmojo.com/news/result-analysis/nath-bio-genes-q4-fy26-profit-wipeout-amid-tax-anomaly-raises-red-flags-3975973", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_quaterlyResult_3975973.png", "date": "2026-05-05 09:49:12", "description": "Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹330.86 crores, reported a shocking loss of ₹0.01 crores for Q4 FY26, marking a complete reversal from the ₹0.94 crores profit posted in Q4 FY25. The stock plunged 7.87% on May 5, 2026, closing at ₹174.45, as investors reacted to an extraordinary tax charge that exceeded the company's pre-tax profit—a rare accounting anomaly that signals potential earnings quality concerns." } ], "total": 169, "sid": "628630", "stock_news_url": "https://www.marketsmojo.com/news/nath-bio-genes-india-628630" }, "announcements": [ { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "28-May-2026", "details": "Annual Secretarial Compliance Report for 31st March 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "11-May-2026", "details": "Earning Call Transcript held on 05th May 2026", "source": "BSE" }, { "caption": "NBIL Concall", "datetime": "11-May-2026", "details": "Audio Transcript of Concall held on 05th May 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 5: Profit wipeout amid tax anomaly raises red flags

May 6: Flat quarterly performance reported with mixed financial trends

May 8: Week closes at Rs.171.15, down 9.61%

Read full news article

Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends

2026-05-06 11:00:16

Nath Bio-Genes (India) Ltd has reported a flat financial performance for the quarter ended March 2026, signalling a stabilisation after a period of decline. While net sales have shown robust growth, profitability metrics and earnings per share continue to face headwinds, reflecting a complex financial landscape for this micro-cap player in the Other Agricultural Products sector.

Read full news article

Are Nath Bio-Genes (India) Ltd latest results good or bad?

2026-05-05 19:16:48

Nath Bio-Genes (India) Ltd reported its financial results for Q4 FY26, revealing a complex operational landscape. The company experienced a net profit of -₹0.01 crores, reflecting a significant decline of 100.68% year-on-year. This loss was primarily driven by an unusually high effective tax rate of 100.40%, which exceeded the pre-tax profit of ₹2.49 crores, effectively nullifying earnings for the quarter. In terms of revenue, Nath Bio-Genes recorded net sales of ₹51.59 crores, which represents a slight decline of 0.73% compared to the same quarter last year. However, this figure marked a more pronounced quarter-on-quarter decrease of 21.79% from ₹65.96 crores in Q3 FY26, indicating volatility in sales performance. The operating margin improved to 8.68%, a notable increase from 0.79% in Q4 FY25, suggesting some operational efficiency gains despite the overall profit loss. The company’s financial performa...

Read full news article

Nath Bio-Genes Q4 FY26: Profit Wipeout Amid Tax Anomaly Raises Red Flags

2026-05-05 09:49:12

Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹330.86 crores, reported a shocking loss of ₹0.01 crores for Q4 FY26, marking a complete reversal from the ₹0.94 crores profit posted in Q4 FY25. The stock plunged 7.87% on May 5, 2026, closing at ₹174.45, as investors reacted to an extraordinary tax charge that exceeded the company's pre-tax profit—a rare accounting anomaly that signals potential earnings quality concerns.

Read full news article